Sebia SA:企業の製品パイプライン分析2018

【英語タイトル】Sebia SA - Product Pipeline Analysis, 2018 Update

GlobalDataが出版した調査資料(DATA904C12189)・商品コード:DATA904C12189
・発行会社(調査会社):GlobalData
・発行日:2018年12月
・ページ数:35
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥162,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥243,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Sebia SA (Sebia) is a medical device company that designs, manufactures, commercializes, and exports electrophoresis tests and analyzers. The company’s electrophoresis program offers automated system for capillary electrophoresis, gel electrophoresis and electrophoresis scanning software. It also provides scientific and technical assistance services. Sebia offers automated system for capillary electrophoresis products such as capillarys 2 flex piercing, capillarys hr, neurosoft and minicap protein 6, among others. The company’s products are used in treatment of multiple myeloma, diabetes, hemoglobin disorders, alcoholisim, and others. It serves medical laboratories across France. Sebia is headquartered at Paris, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Sebia SA
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Sebia SA Company Overview 5
Sebia SA Company Snapshot 5
Sebia SA Pipeline Products and Ongoing Clinical Trials Overview 5
Sebia SA – Pipeline Analysis Overview 8
Sebia SA – Key Facts 8
Sebia SA – Major Products and Services 9
Sebia SA Pipeline Products by Development Stage 11
Sebia SA Pipeline Products Overview 13
Capillarys 3 Octa Analyzer 13
Capillarys 3 Octa Analyzer Product Overview 13
Capillarys 3 Tera – CDT Assay 14
Capillarys 3 Tera – CDT Assay Product Overview 14
Capillarys 3 Tera – HbA1c Capillary Blood Assay 15
Capillarys 3 Tera – HbA1c Capillary Blood Assay Product Overview 15
Capillarys 3 Tera – Hemoglobin Adult Guthrie Assay 16
Capillarys 3 Tera – Hemoglobin Adult Guthrie Assay Product Overview 16
Capillarys 3 Tera – Hemoglobin Neonatal Cord Blood Assay 17
Capillarys 3 Tera – Hemoglobin Neonatal Cord Blood Assay Product Overview 17
Capillarys 3 Tera – Hemoglobin Neonatal Guthrie Assay 18
Capillarys 3 Tera – Hemoglobin Neonatal Guthrie Assay Product Overview 18
Capillarys 3 Tera – Hemoglobin Whole Blood Assay 19
Capillarys 3 Tera – Hemoglobin Whole Blood Assay Product Overview 19
Capillarys 3 Tera Assay – Protein HR 20
Capillarys 3 Tera Assay – Protein HR Product Overview 20
Capillarys 3 Tera Assay – Urine 21
Capillarys 3 Tera Assay – Urine Product Overview 21
Capillarys 3 Tera Assay – Urine IT 22
Capillarys 3 Tera Assay – Urine IT Product Overview 22
Capillarys 3 Tera MC Analyzer 23
Capillarys 3 Tera MC Analyzer Product Overview 23
CAPILLARYS 3 TERA TLA Analyzer 24
CAPILLARYS 3 TERA TLA Analyzer Product Overview 24
Diagnostic Test – Haemoglobin Diseases 25
Diagnostic Test – Haemoglobin Diseases Product Overview 25
Hydrashift 2/4 Daratumumab Assay 26
Hydrashift 2/4 Daratumumab Assay Product Overview 26
Sebia SA – Key Competitors 27
Sebia SA – Key Employees 28
Sebia SA – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Sebia SA, Recent Developments 30
Jan 24, 2018: Sebia Announces FDA Clearance for its Hydrashift 2/4 daratumumab assay 30
Jun 10, 2015: Sebia brings to market new Capillarys 3 Tera automated system with CE mark HbA1c and serum protein testing, and immunotyping 30
Jan 09, 2013: Sebia Receives FDA 510(k) Clearance For Capillarys Hb A1c Kit 31
Appendix 32
Methodology 32
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Sebia SA Pipeline Products and Ongoing Clinical Trials Overview 5
Sebia SA Pipeline Products by Equipment Type 6
Sebia SA Pipeline Products by Indication 7
Sebia SA, Key Facts 8
Sebia SA, Major Products and Services 9
Sebia SA Number of Pipeline Products by Development Stage 11
Sebia SA Pipeline Products Summary by Development Stage 12
Capillarys 3 Octa Analyzer - Product Status 13
Capillarys 3 Octa Analyzer - Product Description 13
Capillarys 3 Tera - CDT Assay - Product Status 14
Capillarys 3 Tera - CDT Assay - Product Description 14
Capillarys 3 Tera - HbA1c Capillary Blood Assay - Product Status 15
Capillarys 3 Tera - HbA1c Capillary Blood Assay - Product Description 15
Capillarys 3 Tera - Hemoglobin Adult Guthrie Assay - Product Status 16
Capillarys 3 Tera - Hemoglobin Adult Guthrie Assay - Product Description 16
Capillarys 3 Tera - Hemoglobin Neonatal Cord Blood Assay - Product Status 17
Capillarys 3 Tera - Hemoglobin Neonatal Cord Blood Assay - Product Description 17
Capillarys 3 Tera - Hemoglobin Neonatal Guthrie Assay - Product Status 18
Capillarys 3 Tera - Hemoglobin Neonatal Guthrie Assay - Product Description 18
Capillarys 3 Tera - Hemoglobin Whole Blood Assay - Product Status 19
Capillarys 3 Tera - Hemoglobin Whole Blood Assay - Product Description 19
Capillarys 3 Tera Assay - Protein HR - Product Status 20
Capillarys 3 Tera Assay - Protein HR - Product Description 20
Capillarys 3 Tera Assay - Urine - Product Status 21
Capillarys 3 Tera Assay - Urine - Product Description 21
Capillarys 3 Tera Assay - Urine IT - Product Status 22
Capillarys 3 Tera Assay - Urine IT - Product Description 22
Capillarys 3 Tera MC Analyzer - Product Status 23
Capillarys 3 Tera MC Analyzer - Product Description 23
CAPILLARYS 3 TERA TLA Analyzer - Product Status 24
CAPILLARYS 3 TERA TLA Analyzer - Product Description 24
Diagnostic Test - Haemoglobin Diseases - Product Status 25
Diagnostic Test - Haemoglobin Diseases - Product Description 25
Hydrashift 2/4 Daratumumab Assay - Product Status 26
Hydrashift 2/4 Daratumumab Assay - Product Description 26
Sebia SA, Key Employees 28
Sebia SA, Subsidiaries 29
Glossary 34

List of Figures
Sebia SA Pipeline Products by Equipment Type 6
Sebia SA Pipeline Products by Development Stage 11

★調査レポート[Sebia SA:企業の製品パイプライン分析2018] (コード:DATA904C12189)販売に関する免責事項を必ずご確認ください。
★調査レポート[Sebia SA:企業の製品パイプライン分析2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆